Retinoic acid regulates immune responses by promoting IL-22 and modulating S100 proteins in viral hepatitis

Journal of Immunology

Volumn 198, Issue 9, 2017, Pages 3448-3460

  Jie, Zuliang ^a   Liang, Yuejin ^a   Yi, Panpan ^a,b   Tang, Hui ^a   Soong, Lynn ^a   Cong, Yingzi ^a   Zhang, Kangling ^a   Sun, Jiaren ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALVASCULIN; CD3 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 22; L SELECTIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN S 100; RECOMBINANT INTERLEUKIN 22; RETINOIC ACID; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; S100A4 PROTEIN, MOUSE;

ADENOVIRUS INFECTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; EFFECTOR CELL; FEMALE; GAMMA DELTA T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LIVER INJURY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; VIRUS HEPATITIS; ADENOVIRIDAE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELLULAR IMMUNITY; DRUG EFFECTS; GENETICS; HEPATITIS, VIRAL, ANIMAL; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER; METABOLISM; T LYMPHOCYTE; VIROLOGY;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; HEPATITIS, VIRAL, ANIMAL; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; INTERLEUKINS; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; S100 CALCIUM-BINDING PROTEIN A4; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRETINOIN;

EID: 85018478260     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601891     Document Type: Article

References (74)

1. Wu, Z., M. Han, T. Chen, W. Yan, and Q. Ning. 2010. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int. 30: 782-794.
2. Hou, L., Z. Jie, M. Desai, Y. Liang, L. Soong, T. Wang, and J. Sun. 2013. Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitis. J. Immunol. 190: 621-629.
3. Bakdash, G., L. T. Vogelpoel, T. M. van Capel, M. L. Kapsenberg, and E. C. de Jong. 2015. Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells. Mucosal Immunol. 8: 265-278.
4. Dunham, R. M., M. Thapa, V. M. Velazquez, E. J. Elrod, T. L. Denning, B. Pulendran, and A. Grakoui. 2013. Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid. J. Immunol. 190: 2009-2016.
5. Feng, T., Y. Cong, H. Qin, E. N. Benveniste, and C. O. Elson. 2010. Generation of mucosal dendritic cells from bone marrow reveals a critical role of retinoic acid. J. Immunol. 185: 5915-5925.
6. Radaeva, S., L. Wang, S. Radaev, W. I. Jeong, O. Park, and B. Gao. 2007. Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G809-G816.
7. Lee, Y. S., and W. I. Jeong. 2012. Retinoic acids and hepatic stellate cells in liver disease. J. Gastroenterol. Hepatol. 27(Suppl. 2): 75-79.
8. Fickenscher, H., S. Hör, H. Küpers, A. Knappe, S. Wittmann, and H. Sticht. 2002. The interleukin-10 family of cytokines. Trends Immunol. 23: 89-96.
9. Zheng, Y., D. M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and W. Ouyang. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651.
10. Eyerich, S., K. Eyerich, D. Pennino, T. Carbone, F. Nasorri, S. Pallotta, F. Cianfarani, T. Odorisio, C. Traidl-Hoffmann, H. Behrendt, et al. 2009. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119: 3573-3585.
11. Simonian, P. L., F. Wehrmann, C. L. Roark, W. K. Born, R. L. OBrien, and A. P. Fontenot. 2010. gd T cells protect against lung fibrosis via IL-22. J. Exp. Med. 207: 2239-2253.
12. Kumar, P., M. S. Thakar, W. Ouyang, and S. Malarkannan. 2013. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol. 6: 69-82.
13. Zindl, C. L., J. F. Lai, Y. K. Lee, C. L. Maynard, S. N. Harbour, W. Ouyang, D. D. Chaplin, and C. T. Weaver. 2013. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc. Natl. Acad. Sci. USA 110: 12768-12773.
14. Sonnenberg, G. F., L. A. Monticelli, M. M. Elloso, L. A. Fouser, and D. Artis. 2011. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34: 122-134.
15. Mielke, L. A., S. A. Jones, M. Raverdeau, R. Higgs, A. Stefanska, J. R. Groom, A. Misiak, L. S. Dungan, C. E. Sutton, G. Streubel, et al. 2013. Retinoic acid expression associates with enhanced IL-22 production by gd T cells and innate lymphoid cells and attenuation of intestinal inflammation. J. Exp. Med. 210: 1117-1124.
16. Radaeva, S., R. Sun, H. N. Pan, F. Hong, and B. Gao. 2004. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39: 1332-1342.
17. Park, O., H. Wang, H. Weng, L. Feigenbaum, H. Li, S. Yin, S. H. Ki, S. H. Yoo, S. Dooley, F.-S. Wang, et al. 2011. In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 54: 252-261.
18. Ki, S. H., O. Park, M. Zheng, O. Morales-Ibanez, J. K. Kolls, R. Bataller, and B. Gao. 2010. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52: 1291-1300.
19. Yang, L., Y. Zhang, L.Wang, F. Fan, L. Zhu, Z. Li, X. Ruan, H. Huang, Z. Wang, Z. Huang, et al. 2010. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J. Hepatol. 53: 339-347.
20. Zhang, Y., M. A. Cobleigh, J. Q. Lian, C. X. Huang, C. J. Booth, X. F. Bai, and M. D. Robek. 2011. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 141: 1897-1906.
21. Liang, S. C., C. Nickerson-Nutter, D. D. Pittman, Y. Carrier, D. G. Goodwin, K. M. Shields, A. J. Lambert, S. H. Schelling, Q. G. Medley, H. L. Ma, et al. 2010. IL-22 induces an acute-phase response. J. Immunol. 185: 5531-5538.
22. Foster, R. G., L. Golden-Mason, A. Rutebemberwa, and H. R. Rosen. 2012. Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection. Dig. Dis. Sci. 57: 381-389.
23. Velazquez, V. M., H. Hon, C. Ibegbu, S. J. Knechtle, A. D. Kirk, and A. Grakoui. 2012. Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. Hepatology 56: 2071-2081.
24. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
25. MartIn-Fontecha, A., S. Sebastiani, U. E. Höpken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198: 615-621.
26. Liang, Y., Z. Jie, L. Hou, P. Yi, W. Wang, Z. Kwota, M. Salvato, R. de Waal Malefyt, L. Soong, and J. Sun. 2015. IL-33 promotes innate IFN-g production and modulates dendritic cell response in LCMV-induced hepatitis in mice. Eur. J. Immunol. 45: 3052-3063.
27. Jie, Z., Y. Liang, L. Hou, C. Dong, Y. Iwakura, L. Soong, Y. Cong, and J. Sun. 2014. Intrahepatic innate lymphoid cells secrete IL-17A and IL-17F that are crucial for T cell priming in viral infection. J. Immunol. 192: 3289-3300.
28. Bhatt, S., J. Qin, C. Bennett, S. Qian, J. J. Fung, T. A. Hamilton, and L. Lu. 2014. All-Trans retinoic acid induces arginase-1 and inducible nitric oxide synthaseproducing dendritic cells with T cell inhibitory function. J. Immunol. 192: 5098-5108.
29. Yan, J., Z. Jie, L. Hou, J. L. Wanderley, L. Soong, S. Gupta, S. Qiu, T. Chan, and J. Sun. 2011. Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice. Hepatology 53: 1455-1467.
30. Xin, L., K. Li, and L. Soong. 2008. Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes. Mol. Immunol. 45: 3371-3382.
31. Henderson, S. E., K. S. Santangelo, and A. L. Bertone. 2011. Chondrogenic effects of exogenous retinoic acid or a retinoic acid receptor antagonist (LE135) on equine chondrocytes and bone marrow-derived mesenchymal stem cells in monolayer culture. Am. J. Vet. Res. 72: 884-892.
32. Xu, J., H. Wang, T. Liang, X. Cai, X. Rao, Z. Huang, and G. Sheng. 2012. Retinoic acid promotes neural conversion of mouse embryonic stem cells in adherent monoculture. Mol. Biol. Rep. 39: 789-795.
33. Qi, H., V. Popov, and L. Soong. 2001. Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo. J. Immunol. 167: 4534-4542.
34. Knodell, R. G., K. G. Ishak, W. C. Black, T. S. Chen, R. Craig, N. Kaplowitz, T. W. Kiernan, and J. Wollman. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431-435.
35. Liang, Y., Z. Jie, L. Hou, R. Aguilar-Valenzuela, D. Vu, L. Soong, and J. Sun. 2013. IL-33 induces nuocytes and modulates liver injury in viral hepatitis. J. Immunol. 190: 5666-5675.
36. Liang, Y. J., J. Luo, Q. Yuan, D. Zheng, Y. P. Liu, L. Shi, Y. Zhou, A. L. Chen, Y. Y. Ren, K. Y. Sun, et al. 2011. New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum. PLoS One 6: e20247.
37. Mederacke, I., D. H. Dapito, S. Affo, H. Uchinami, and R. F. Schwabe. 2015. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat. Protoc. 10: 305-315.
38. Roark, C. L., P. L. Simonian, A. P. Fontenot, W. K. Born, and R. L. OBrien. 2008. gammadelta T cells: An important source of IL-17. Curr. Opin. Immunol. 20: 353-357.
39. Weichhart, T., G. Costantino, M. Poglitsch, M. Rosner, M. Zeyda, K. M. Stuhlmeier, T. Kolbe, T. M. Stulnig, W. H. Hörl, M. Hengstschläger, et al. 2008. The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29: 565-577.
40. Nauc, V., E. De Lamirande, P. Leclerc, and C. Gagnon. 2004. Inhibitors of phosphoinositide 3-kinase, LY294002 and wortmannin, affect sperm capacitation and associated phosphorylation of proteins differently: Ca2+-dependent divergences. J. Androl. 25: 573-585.
41. Belz, G., A. Mount, and F. Masson. 2009. Dendritic cells in viral infections. Handb. Exp. Pharmacol. 188: 51-77.
42. Rodrigue-Gervais, I. G., H. Rigsby, L. Jouan, D. Sauvé, R. P. Sékaly, B.Willems, and D. Lamarre. 2010. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection. J. Immunol. 184: 3134-3144.
43. Inaba, K., J. P. Metlay, M. T. Crowley, and R. M. Steinman. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172: 631-640.
44. Li, Z. H., N. G. Dulyaninova, R. P. House, S. C. Almo, and A. R. Bresnick. 2010. S100A4 regulates macrophage chemotaxis. Mol. Biol. Cell 21: 2598-2610.
45. Boomershine, C. S., A. Chamberlain, P. Kendall, A. R. Afshar-Sharif, H. Huang, M. K. Washington, W. E. Lawson, J. W. Thomas, T. S. Blackwell, and N. A. Bhowmick. 2009. Autoimmune pancreatitis results from loss of TGFbeta signalling in S100A4-positive dendritic cells. Gut 58: 1267-1274.
46. Hilly, O., R. Koren, R. Raz, L. Rath-Wolfson, A. Mizrachi, Y. Hamzany, G. Bachar, and T. Shpitzer. 2013. The role of s100-positive dendritic cells in the prognosis of papillary thyroid carcinoma. Am. J. Clin. Pathol. 139: 87-92.
47. Zeid, N. A., and H. K. Muller. 1993. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 25: 338-343.
48. Wilson, A. J., P. H. Maddox, and D. Jenkins. 1991. CD1a and S100 antigen expression in skin Langerhans cells in patients with breast cancer. J. Pathol. 163: 25-30.
49. Li, Z. H., and A. R. Bresnick. 2006. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res. 66: 5173-5180.
50. Lu, L., Q. Lan, Z. Li, X. Zhou, J. Gu, Q. Li, J. Wang, M. Chen, Y. Liu, Y. Shen, et al. 2014. Critical role of all-Trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc. Natl. Acad. Sci. USA 111: E3432-E3440.
51. Ichikawa, S., D. Mucida, A. J. Tyznik, M. Kronenberg, and H. Cheroutre. 2011. Hepatic stellate cells function as regulatory bystanders. J. Immunol. 186: 5549-5555.
52. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1: 433-442.
53. Hall, J. A., J. L. Cannons, J. R. Grainger, L. M. Dos Santos, T. W. Hand, S. Naik, E. A. Wohlfert, D. B. Chou, G. Oldenhove, M. Robinson, et al. 2011. Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. Immunity 34: 435-447.
54. Allie, S. R., W. Zhang, C. Y. Tsai, R. J. Noelle, and E. J. Usherwood. 2013. Critical role for all-Trans retinoic acid for optimal effector and effector memory CD8 T cell differentiation. J. Immunol. 190: 2178-2187.
55. Tan, X., J. L. Sande, J. S. Pufnock, J. N. Blattman, and P. D. Greenberg. 2011. Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge. J. Virol. 85: 8316-8327.
56. Iwata, M., Y. Eshima, and H. Kagechika. 2003. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int. Immunol. 15: 1017-1025.
57. Elias, K. M., A. Laurence, T. S. Davidson, G. Stephens, Y. Kanno, E. M. Shevach, and J. J. OShea. 2008. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111: 1013-1020.
58. Xiao, S., H. Jin, T. Korn, S. M. Liu, M. Oukka, B. Lim, and V. K. Kuchroo. 2008. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181: 2277-2284.
59. Benson, M. J., K. Pino-Lagos, M. Rosemblatt, and R. J. Noelle. 2007. All-Trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204: 1765-1774.
60. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Cárcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764.
61. Kang, S. G., H. W. Lim, O. M. Andrisani, H. E. Broxmeyer, and C. H. Kim. 2007. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol. 179: 3724-3733.
62. Thatcher, J. E., and N. Isoherranen. 2009. The role of CYP26 enzymes in retinoic acid clearance. Expert Opin. Drug Metab. Toxicol. 5: 875-886.
63. Muruve, D. A. 2004. The innate immune response to adenovirus vectors. Hum. Gene Ther. 15: 1157-1166.
64. Xiang, X., H. Gui, N. J. King, L. Cole, H. Wang, Q. Xie, and S. Bao. 2012. IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver. Immunol. Cell Biol. 90: 611-619.
65. Dambacher, J., F. Beigel, K. Zitzmann, M. H. Heeg, B. Göke, H. M. Diepolder, C. J. Auernhammer, and S. Brand. 2008. The role of interleukin-22 in hepatitis C virus infection. Cytokine 41: 209-216.
66. Hennig, B. J., A. J. Frodsham, S. Hellier, S. Knapp, L. J. Yee, M. Wright, L. Zhang, H. C. Thomas, M. Thursz, and A. V. Hill. 2007. Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection. Liver Int. 27: 1134-1143.
67. Zhao, J., Z. Zhang, Y. Luan, Z. Zou, Y. Sun, Y. Li, L. Jin, C. Zhou, J. Fu, B. Gao, et al. 2014. Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology 59: 1331-1342.
68. Chi, H. 2012. Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12: 325-338.
69. Lau, A. H., and A. W. Thomson. 2003. Dendritic cells and immune regulation in the liver. Gut 52: 307-314.
70. Barbier, L., S. S. Tay, C. McGuffog, J. A. Triccas, G. W. McCaughan, D. G. Bowen, and P. Bertolino. 2012. Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation. J. Hepatol. 57: 352-358.
71. Randolph, G. J., V. Angeli, and M. A. Swartz. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5: 617-628.
72. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
73. Wherry, E. J. 2011. T cell exhaustion. Nat. Immunol. 12: 492-499.
74. Lee, Y. S., H. S. Yi, Y. G. Suh, J. S. Byun, H. S. Eun, S. Y. Kim, W. Seo, J. M. Jeong, W. M. Choi, M. H. Kim, et al. 2015. Blockade of retinol metabolism protects T cell-induced hepatitis by increasing migration of regulatory T cells. Mol. Cells 38: 998-1006.